• Categories
  • Archives

Brazilian Government to Make Drugs at the Tune of 10 Billion Units

Brazil’s Oswaldo Cruz Foundation plans to increase its production of remedies in its laboratories in Rio de Janeiro from 1.7 billion to 10 billion units. The remedies are distributed free of cost to the population.

The increase in production capacity is due to the purchase, for US$ 6 million, of a laboratory that belonged to the Glaxo do Brasil company.


The executive director of the Fiocruz Institute of Drug Technology, Núbia Boechat, explains that the acquisition of the new factory will reduce the government’s outlays on drug purchases.


“The savings will amount to US$ 3.6 million (10 million reais) with the new laboratory.”


In 2003, the production of Fiocruz’s Farmanguinhos laboratory saved the federal governmnet US$ 72.3 million (200 million reais), she informed.


According to Boechat, the laboratories will manufacture antibiotics, for the first time.


“Since the laboratory that was acquired has elevated technological standards, our production lines will be expanded. At present we work basically in the area of solids and semi-solids, pills, creams, and ointments.


“Now we shall have productions lines for sprays, asthma medicines, and antibiotics,” she explains.


She also underscores the superior quality of the medications produced by Fiocruz.


“Brazil has a very significant pioneering effort. We are the only country in the world with a network of 18 government laboratories, five of them medium in size, all very well organized.


“The medicines are used by the Federal Health System and the government’s programs for needy citizens. Moreover, the government laboratories are the sole producers of drugs for tuberculosis, Chagas’s disease, leishmaniosis, Hansen’s disease, and others.


“These diseases offer no incentive for large pharmaceutical companies, because the profits are low,” she observes.


In Boechat’s opinion, the acquisition of the Glaxo laboratory will directly benefit the Brazilian population.


“We have up-to-date equipment and trained personnel that work from the development of the remedy to quality control. Our motto is to produce high quality remedies for the needy population,” she concludes.


Agência Brasil
Translator: David Silberstein

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Brazil’s Lula Wants UN to Help Immigrants Send Money Back Home

After participating in the opening ceremony of a United Nations (UN) Security Council meeting, ...

Walfrido dos Mares Guia, Brazil's Minister for Institutional Relations

Brazil’s Lula Joins Former Conservative Foes to Rule and Remain in Power

Luiz Inácio Lula da Silva, president of Brazil, would like to see his ruling ...

11,000 Brazilians Found in Slave Work in 3 Years

The number of people freed from slave work in Brazil, during the first 10 ...

40% of Young Brazilians Don’t Know How AIDS Is Transmitted

600 thousand of Latin America’s total of 1.8 million HIV carriers live in Brazil, ...

Brazil’s Lula Lambasts US

President Bush is expected to call at the UN for international assistance in Iraq ...

Disrobed Women, Alcohol, Floats. World’s Biggest Street Party Is on in Brazil

Brazil beauties with nothing for clothing but sequins led Carnaval parades lasting until dawn ...

Brazil Pushes Panic Button and Slaps Restrictions on 60% of Imports

The Brazilian government announced it has imposed restrictions on 60% of imports "to soften" ...

Oversea Prices Lead Brazil’s Usiminas to Top US$ 1 Bi in Net Income

Usinas Siderúrgicas de Minas Gerais S/A announced February 25 its fourth quarter 2004  and ...

Itaú-Unibanco Bank Merger Gets Brazil’s Seal of Approval

A year and nine months after the merger of two of Brazil’s largest private ...

Lula: Despite Higher Primary Surplus Brazil Remains on Track

The government has decided to raise its primary account surplus target from 4.25% of ...